Celcuity Inc. Common Stock

CELC trades at its 52-week high with a microscopic $5.7B market cap for a pre-profitable healthcare services company, yet carries a staggering 27.49% short interest—more than double typical levels. The RSI of 56.9 suggests neither overbought nor oversold conditions, but the combination of extremes paints a precarious picture: limited liquidity in a tiny-cap stock paired with substantial bearish positioning creates classic squeeze mechanics. The absence of a meaningful P/E ratio confirms the company burns cash rather than generates earnings, making this a pure speculative bet on future profitability. This setup screams volatility risk in both directions.